By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Castle Creek Pharmaceuticals, LLC, a global company dedicated to delivering transformative therapies to patients with dermatologic and head/neck orphan diseases and underserved conditions, announced completion of an exclusive license agreement for all U.S. rights to Arlevert
LOS ANGELES Wednesday AHF lauded the publication of clinical trial results in the journal Lancet which showed 100 percent efficacy in preventing Ebola virus infection among study participants who received an experimental vaccine in Sierra Leone and Guinea. Every year the world collectively spends almost $2 trillion on defense and only $36 billio
The FDA issued an earlier set of recommendations in October 2014, which recommended ways for manufacturers to build cybersecurity protections into medical devices as they`re being designed and developed. The FDA recommends manufacturers continually monitor cybersecurity vulnerabilities of devices and should create a program to mitigate these risks.
Dec. 31 The Affordable Care Act President Barack Obama's landmark health reform bill took some hits in 2016, but it could be in for a real beatdown this year. It's unclear what will become of the Affordable Care Act under a Donald Trump presidency. "It was a difficult year because of the departures by insurers," said Paul Ginsburg, director
-Zion Research has published a new report Titled Blood Pressure Monitoring Device Market by Device Type and by Accessory Type for Hospitals, Homecare, Diagnostics Laboratory and Others Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 2021. According to the report, the globalblood pressure monitoring device marketaccounted for.
By a News Reporter-Staff News Editor at Investment Weekly News Research and Markets has announced the addition of the "Outpatient Care Centers Global Market Briefing 2017" report to their offering. The Outpatient Care Centers Global Market Briefing provides strategists, marketers and senior management with the critical information they need to as
Sri Lanka`s Minister of Health Dr. Rajitha Senaratne has decided to reduce the prices of surgical equipment, coinciding with the move to slash the prices of essential medicinal drugs. Minister Rajitha Senaratne has given instructions to the National Drugs Regulatory Authority to draft a proper mechanism to reduce the prices of surgical equipment.
Humacyte, an innovator in biotechnology and regenerative medicine, announced today the initiation of a U.S. Phase II arterial bypass clinical trial of HUMACYL, its investigational human acellular vessel, to test the safety and efficacy as a lower extremity arterial bypass vessel in patients with peripheral arterial disease. The initiation of the Ph
Pharmaceutical company Lupin has received tentative approval from the United States Food and Drug Administration to market its cholesterol lowering Pitavastatin tablets in the American market. has received approval for Pitavastatin tablets in the strength of 1 milligram, 2 mg and 4 mg. Pitavastatin is a generic version of Kowa's Livalo tablets in t
The medical power supply devices market is estimated to be valued at US$ 1,263.3 Mn by the end of 2016 and is anticipated to expand at a CAGR of 4.5% from 2016 to 2022, to account for US$ 1,613.9 Mn by 2022.. Power supply devices, also known as electric power converters, are electronic devices that convert one form of electrical energy into another
Its three diagnostic imaging centers in the Naples area will be acquired by the NCH Healthcare System, effective Jan. 1. All of the centers will remain open and will be combined with NCH's existing outpatient radiology offices to create NCH Imaging, said Debbie Curry, a spokeswoman for NCH, in an email. NDIC has operated as an NCH affiliate, with r
By a News Reporter-Staff News Editor at Marketing Weekly News The biopharmaceutical company Dompe announced the acceptance of the registration application submitted to the European Medicines Agency for Oxervate eye drops, for the treatment of moderate and severe neurotrophic keratitis in adult patients. Acceptance by EMA constitutes the...
HONOLULU Eager to stop Republicans from destroying his signature health care law, President Barack Obama and Democratic lawmakers will meet next week to try to forge a common strategy. The White House is casting it as an effort to unite Democrats behind a plan to protect the law, known as the Affordable Care Act, before Republicans have a chance to
In 2016, many new and useful medications got FDA approval. My articles are syndicated worldwide, but I'm only listing English drug names so please ask your local pharmacist to translate the medication name for your country. So the FDA approved this injectable drug to help people who have been exposed from infected animals, contaimated animal produc
Heavy Metal and makeup have more in common than you might know. Lipsticks, mascara, sunblock, and deodorant are just a few of the toxic products that contain levels of heavy metals and other substances that are unregulated by the FDA. Unlike drug companies, cosmetics companies may use almost any ingredients they choose, with few exceptions.
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors Tamarkin, Dov; Friedman, Doron; Eini, Meir, filed on August 16, 2016, was made available online on December 15, 2016, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a co
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventor Radmer, Bo, filed on February 23, 2015, was made available online on December 15, 2016, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Novo Nordisk A/S. The following quote was obt
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventor Morrison, Mark Steven, filed on June 3, 2016, was made available online on December 15, 2016, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Microdose Therapeutx, Inc.. The followi
Gainers Marinus Pharmaceuticals Inc rose 29.3 percent to $1.080 in pre-market trading as the company disclosed that ganaxolone has received Orphan Drug designation for the treatment of Fragile X Syndrome. China Cord Blood Corp shares rose 16.1 percent to $6.35 in pre-market trading after Golden Meditech agreed to sell its equity interest in China C
By a News Reporter-Staff News Editor at Drug Week Ab Initio Biotherapeutics, Inc., announced a collaborative research and license agreement with Pfizer Inc. that aims to discover novel therapeutic antibodies against an undisclosed target in the G-protein coupled receptor superfamily. Pfizer has exclusive worldwide rights to develop and commercial
ABBOTT PARK, Illinois, Dec. 30, 2016/ PRNewswire/ Abbott announced today it intends to close the acquisition of St. Jude Medical, Inc., on Wednesday, Jan. 4, 2017. "We continue to deliberately shape our business for long-term success by securing leadership positions in attractive markets and focusing on customer needs," said Miles D. White, chai
Dec. 30 Abbott Laboratories intends to close its deal to buy medical device maker St. Jude Medical just after the new year, now that it has received permission from U.S. and international antitrust regulators scrutinizing the $25 billion deal. Abbott Labs, based in suburban Chicago, said Friday it intends to close the deal on Jan. 4; originally,
Shares of Abbott Labs underperformed the Zacks classified Large Cap Pharmaceuticals industry in the year-to-date period. Coming back to the latest news, the divestment will ensure fair competition in the U.S. markets for medical devices used in cardiac and vascular catheterization. Note that the FTC had alleged that the proposed acquisition would i
By a News Reporter-Staff News Editor at Health& Medicine Week Acerus Pharmaceuticals Corporation announced the signing of an agreement granting the exclusive right to market NATESTO in South Korea to Hyundai Pharm Co., LTD., a South Korean pharmaceutical company. "Hyundai has a proven track record of success in launching products, building ne
The Medicines and Healthcare products Regulatory Agency is focussed on protecting and promoting public health through its three centres: Clinical Practice Research Datalink, National Institute for Biological Standards and Control and MHRA. The number of first in human clinical trials carried out in the UK is also increasing. This is significant as